Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Kala Pharmaceuticals Inc

CUSIP: 483119953 | 6 institutional holders

Quarters

Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile